760346

    544647

    NEPHROPLUS

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Nephrocare Health Serv L Share Price Today

    NEPHROCARE HEALTH SERV L is currently trading at ₹683.8, up by ₹0.7 from the previous close. During the latest trading session, the stock touched an intraday high of ₹691.55 and a low of ₹662.60. Over the past six months, NEPHROCARE HEALTH SERV L has delivered a return of 44.64%, while the stock has gained 0.63% in the last one month.

    Nephrocare Health Serv L performance

    Today’s low Today’s high
    ₹ 662.60 ₹ 691.55
    ₹ 681.65
    52 week low 52 week high
    ₹ 446.00 ₹ 769.75
    ₹ 681.65
    Open Price ₹ 684.70
    Prev. Close ₹ 683.10
    Volume (Shares) 77557.00
    Total traded value ₹ 528.66
    Upper Circuit ₹ 819.70
    Lower Circuit ₹ 546.50
    info

    Investment Returns

    Over 1 Month 0.63% Over 3 Months 28.79% Over 6 Months 30.74% Over 1 Year 44.64%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Nephrocare Health Serv L fundamentals


    • Market cap (Cr) 6,854.60
    • P/E Ratio (TTM) 0.00
    • Beta 0.70
    • Book Value / share 96.55
    • Return on equity 0.00%
    • EPS (TTM) 0.00
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 10.89
    info icon alternate text
    • Market cap (Cr) 6,855.60
    • P/E Ratio (TTM) 0.00
    • Beta 0.67
    • Book Value / share 96.55
    • Return on equity 0.00%
    • EPS (TTM) 0.00
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 10.89
    info icon alternate text

    Nephrocare Health Serv L Financials

    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 164.33
    Operating Expense 159.47
    Net Profit 10.89
    Net Profit Margin (%) 6.62
    Earnings Per Share (EPS) 1.09
    EBITDA 28.21
    Effective Tax Rate (%) 1.00
    Particulars DEC 2025 (Values in Cr)
    Revenue 160.66
    Operating Expense 155.17
    Net Profit 8.45
    Net Profit Margin (%) 5.25
    Earnings Per Share (EPS) 0.90
    EBITDA 26.33
    Effective Tax Rate (%) 5.69
    Particulars SEP 2025 (Values in Cr)
    Revenue 155.92
    Operating Expense 189.41
    Net Profit -32.41
    Net Profit Margin (%) -20.78
    Earnings Per Share (EPS) -3.82
    EBITDA 26.33
    Effective Tax Rate (%) -5.87
    Particulars JUN 2025 (Values in Cr)
    Revenue 148.83
    Operating Expense 0.00
    Net Profit 5.01
    Net Profit Margin (%) 3.36
    Earnings Per Share (EPS) 0.50
    EBITDA 0.00
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 145.01
    Operating Expense 140.33
    Net Profit 5.67
    Net Profit Margin (%) 3.91
    Earnings Per Share (EPS) 0.70
    EBITDA 24.49
    Effective Tax Rate (%) 23.45
    Particulars MAR 2026 (Values in Cr)
    Revenue 629.74
    Operating Expense 648.95
    Net Profit -8.06
    Net Profit Margin (%) -1.27
    Earnings Per Share (EPS) -0.89
    EBITDA 103.60
    Effective Tax Rate (%) -113.79
    Particulars MAR 2025 (Values in Cr)
    Revenue 543.60
    Operating Expense 513.87
    Net Profit 34.24
    Net Profit Margin (%) 6.29
    Earnings Per Share (EPS) 4.23
    EBITDA 110.52
    Effective Tax Rate (%) 24.51
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 111.27
    ROE % 8.90
    ROCE % 15.16
    Total Debt to Total Equity 0.20
    EBITDA Margin 24.87
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 3288.65
    ROE % 12.00
    ROCE % 13.01
    Total Debt to Total Equity 0.53
    EBITDA Margin 23.91
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 2345.99
    ROE % 7.87
    ROCE % 7.66
    Total Debt to Total Equity 0.58
    EBITDA Margin 19.33
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 2213.96
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.40
    EBITDA Margin 12.48
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 2254.31
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.39
    EBITDA Margin 8.08
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 96.76
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.10
    EBITDA Margin 16.59
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 3050.09
    ROE % 6.00
    ROCE % 8.10
    Total Debt to Total Equity 0.33
    EBITDA Margin 20.33
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 2291.71
    ROE % 0.87
    ROCE % 2.60
    Total Debt to Total Equity 0.47
    EBITDA Margin 13.72
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 2260.06
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.39
    EBITDA Margin 11.15
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 2346.99
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.38
    EBITDA Margin 6.77
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 255.46
    Total Assets 1470.86
    Total Liabilities 1470.86
    Total Equity 1116.49
    Share Outstanding 10
    Price to Book Ratio 5.22
    Return on Assets (%) 5.22
    Return on Capital (%) 6.74
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 155.38
    Total Assets 996.46
    Total Liabilities 996.46
    Total Equity 584.11
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 6.73
    Return on Capital (%) 8.28
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 61.17
    Total Assets 806.01
    Total Liabilities 806.01
    Total Equity 413.70
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 4.35
    Return on Capital (%) 5.35
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 127.30
    Total Assets 666.23
    Total Liabilities 666.23
    Total Equity 388.63
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) -1.76
    Return on Capital (%) -2.02
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 143.36
    Total Assets 570.64
    Total Liabilities 570.64
    Total Equity 395.99
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) -3.73
    Return on Capital (%) -4.17
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 225.25
    Total Assets 1135.05
    Total Liabilities 1135.05
    Total Equity 970.90
    Share Outstanding 10
    Price to Book Ratio 5.22
    Return on Assets (%) -0.71
    Return on Capital (%) -0.83
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 33.42
    Total Assets 756.61
    Total Liabilities 756.61
    Total Equity 542.00
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 4.52
    Return on Capital (%) 5.15
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 1.64
    Total Assets 664.57
    Total Liabilities 664.57
    Total Equity 404.21
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 0.58
    Return on Capital (%) 0.67
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 3.22
    Total Assets 646.89
    Total Liabilities 646.89
    Total Equity 396.64
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) -2.39
    Return on Capital (%) -2.61
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 128.06
    Total Assets 571.90
    Total Liabilities 571.90
    Total Equity 411.99
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) -3.84
    Return on Capital (%) -4.17
    Particulars MAR 2026 (Values in Cr)
    Net Income 97.47
    Cash from Operations 260.05
    Cash from Investing -410.43
    Cash from Financing 157.10
    Net change in Cash -20.74
    Free Cash Flow 378.99
    Particulars MAR 2025 (Values in Cr)
    Net Income 87.43
    Cash from Operations 136.30
    Cash from Investing -125.07
    Cash from Financing 54.37
    Net change in Cash 64.64
    Free Cash Flow 236.07
    Particulars MAR 2024 (Values in Cr)
    Net Income 33.16
    Cash from Operations 80.34
    Cash from Investing -50.66
    Cash from Financing 26.73
    Net change in Cash 48.35
    Free Cash Flow 157.69
    Particulars MAR 2023 (Values in Cr)
    Net Income -8.59
    Cash from Operations 6.64
    Cash from Investing -78.20
    Cash from Financing 59.96
    Net change in Cash -4.49
    Free Cash Flow 78.21
    Particulars MAR 2022 (Values in Cr)
    Net Income -27.14
    Cash from Operations 19.12
    Cash from Investing -129.29
    Cash from Financing 121.29
    Net change in Cash 6.03
    Free Cash Flow 97.47
    Particulars MAR 2026 (Values in Cr)
    Net Income -3.76
    Cash from Operations 150.76
    Cash from Investing -298.75
    Cash from Financing 255.67
    Net change in Cash 89.82
    Free Cash Flow 226.97
    Particulars MAR 2025 (Values in Cr)
    Net Income 45.36
    Cash from Operations 76.29
    Cash from Investing -103.51
    Cash from Financing 26.02
    Net change in Cash 2.23
    Free Cash Flow 156.05
    Particulars MAR 2024 (Values in Cr)
    Net Income 0.21
    Cash from Operations 59.14
    Cash from Investing -19.25
    Cash from Financing -35.54
    Net change in Cash -1.46
    Free Cash Flow 131.00
    Particulars MAR 2023 (Values in Cr)
    Net Income -12.87
    Cash from Operations 7.19
    Cash from Investing -74.70
    Cash from Financing 63.38
    Net change in Cash -0.17
    Free Cash Flow 43.97
    Particulars MAR 2022 (Values in Cr)
    Net Income -28.07
    Cash from Operations 16.71
    Cash from Investing -167.48
    Cash from Financing 147.37
    Net change in Cash -8.19
    Free Cash Flow 59.68
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8955.00 65.82 13.59 128759.16 6680.00 9099.95
    FORTIS MALAR HOSPITALS LIMITED 50.61 22.90 2.76 94.85 40.75 76.00
    SHREE PACETRONIX LTD. 137.05 16.35 2.88 51.39 71.00 283.15
    TRANSGENE BIOTEK LTD. 3.01 0.00 2.72 22.81 1.83 5.17
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8955.00 85.77 12.92 128759.16 6680.00 9099.95
    [-] 0.0 0.0 0.0 0.0 0.0 0.0
    CHENNAI MEENAKSHI MULTISPECIAL 36.05 0.00 -8.77 26.93 30.30 57.48
    KOVAI MEDICAL CENTER & HO 5916.50 26.30 4.90 6472.65 5010.00 6725.00

    Nephrocare Health Serv L shareholding pattern

    Holding
    18.31%
    63.85%
    8.78%
    9.04%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    Nephrocare Health Serv L Technicals Summary

    681.65 -0.21 redarrow
    red-green-graph indicator
    3 Bearish
    13 Bullish
    • 5 Days 683.70
    • 26 Days 667.70
    • 10 Days 676.20
    • 50 Days 654.80
    • 12 Days 674.00
    • 100 Days 621.40
    • 20 Days 669.70
    • 200 Days 579.10
    691.03 PIVOT
    First Support 673.07 First Resistance 701.07 Second Support 663.03 Second Resistance 719.03 Third Support 645.07 Third Resistance 729.07
    RSI 54.86 ADX 24.38 MACD 6.30 Williams % R -32.22 Commodity Channel Index (CCI) 65.15
    Date 2026-07-31 Week 69762.00 Same Day 42493.00 Month 112095.00
    1 Year 0.71 3 Year 0.70
    Over 1 Month
    0.63% down
    Over 1 Year
    44.64% down
    Over 3 Months
    28.79% down
    Over 3 Years
    0.00% down
    Over 6 Months
    30.74% down
    Over 5 Years
    0.00% down

    Nephrocare Health Serv L Corporate Actions

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Nephrocare Health Services Ltd?

    Answer Field

    Nephrocare Health Services Ltd share price is for NSE ₹ 683.80 & for BSE ₹ 675.00 as on Jul 31 2026 12:48 PM.

    What is the Market Cap of Nephrocare Health Services Ltd Share?

    Answer Field

    The market cap of Nephrocare Health Services Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 31 2026 12:48 PM.

    What is the 52 Week High and Low of Nephrocare Health Services Ltd?

    Answer Field

    The 52 Week High and Low of Nephrocare Health Services Ltd for NSE is ₹ 769.75 and ₹ 446.00 and for BSE is ₹ 767.95 and ₹ 445.00.

    What is 1 year return for Nephrocare Health Services Ltd?

    Answer Field

    The 1 year returns on the stock has been 44.64%.

    What is the P/E Ratio of Nephrocare Health Services Ltd Share?

    Answer Field

    As on Jul 31 2026 12:48 PM the price-to-earnings (PE) ratio for Nephrocare Health Services Ltd share is 0.00.

    What is the PB ratio of Nephrocare Health Services Ltd Share?

    Answer Field

    As on Jul 31 2026 12:48 PM, the price-to-book (PB) ratio for Nephrocare Health Services Ltd share is 96.55.

    How to Buy Nephrocare Health Services Ltd Share?

    Answer Field

    You can trade in Nephrocare Health Services Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Nephrocare Health Services Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Nephrocare Health Services Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Nephrocare Health Services Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |